Digoxin-bound pig kidney Na,K-ATPase structure
Biochemical assay · Purified pig kidney Na+,K+-ATPase α1β1γ stabilized in the E2P state [1]
The crystallographic model places digoxin in the extracellular ion-pathway cavity formed by transmembrane segments αM1–6. The steroid/lactone region extends toward the cation sites and the trisaccharide points toward the extracellular environment. This supports direct pump binding; it does not establish cellular potency or clinical efficacy.
| Endpoint | Reported result | Reference |
|---|---|---|
| Location of bound digoxin in the Na,K-ATPase complex | X-ray crystallographic binding-site assignment Extracellular ion-pathway cavity formed by αM1–6 | [1] |
Literature-Reported Treatment Conditions
- Treatment concentration
- 0.5 mM digoxin during preparation of the E2P–digoxin complex
- Method
- Preincubation of enzyme membrane fraction followed by detergent solubilization and crystallization
- Reported limits
- Preincubation duration and digoxin stock solvent were not specified in the read main-text crystallization method. This concentration is a structural preparation condition.
Methods and source locations
Compound reported in the paper: Digoxin; Compound label in the paper: Digoxin (E2P–digoxin complex)
Compound-level binding evidence from pig kidney enzyme; no supplier-lot equivalence inferred.
Figures 1–2; Results and Discussion; Crystallization and Data Collection; Structure Determination and Refinement
Location of bound digoxin in the Na,K-ATPase complex: X-ray diffraction with molecular replacement and restrained refinement; digoxin and comparative bufalin structures; previously determined ouabain-bound complex used for comparison. — Results and Discussion, structural interpretation; Figures 1C, 1E–F and 2A; Structure Determination and Refinement